199 related articles for article (PubMed ID: 11352853)
21. Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma.
Tanaka S; Tatsuguchi A; Futagami S; Gudis K; Wada K; Seo T; Mitsui K; Yonezawa M; Nagata K; Fujimori S; Tsukui T; Kishida T; Sakamoto C
Gut; 2006 Jan; 55(1):54-61. PubMed ID: 16085694
[TBL] [Abstract][Full Text] [Related]
22. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity.
Mastalerz L; Sanak M; Gawlewicz-Mroczka A; Gielicz A; Cmiel A; Szczeklik A
Thorax; 2008 Jan; 63(1):27-34. PubMed ID: 17584993
[TBL] [Abstract][Full Text] [Related]
24. Relationship between COX-2 expression and clinicopathological features of colorectal cancers.
Zhan J; Liu JP; Zhu ZH; Yao HR; Chen CY
Chin Med J (Engl); 2004 Aug; 117(8):1151-4. PubMed ID: 15361286
[TBL] [Abstract][Full Text] [Related]
25. Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose.
Ruffin MT; Krishnan K; Rock CL; Normolle D; Vaerten MA; Peters-Golden M; Crowell J; Kelloff G; Boland CR; Brenner DE
J Natl Cancer Inst; 1997 Aug; 89(15):1152-60. PubMed ID: 9262254
[TBL] [Abstract][Full Text] [Related]
26. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
[TBL] [Abstract][Full Text] [Related]
28. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
29. Use of NSAIDs for the chemoprevention of colorectal cancer.
Herendeen JM; Lindley C
Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
[TBL] [Abstract][Full Text] [Related]
30. Measurement of prostaglandin E2 in rectal mucosa in human subjects: a method study.
Finley PR; Bogert CL; Alberts DS; Einspahr J; Earnest DL; Blackwell G; Girodias K
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):239-44. PubMed ID: 7606198
[TBL] [Abstract][Full Text] [Related]
31. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells.
Liu CY; Lai YY; Lo CJ
J Surg Res; 2004 Apr; 117(2):223-31. PubMed ID: 15047127
[TBL] [Abstract][Full Text] [Related]
32. Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms.
Sidelnikov E; Bostick RM; Flanders WD; Long Q; Seabrook ME
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2965-73. PubMed ID: 19861524
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of epithelial cell proliferation rate in normal-appearing colonic mucosa as a high-risk marker for colorectal cancer.
Akedo I; Ishikawa H; Ioka T; Kaji I; Narahara H; Ishiguro S; Suzuki T; Otani T
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):925-30. PubMed ID: 11535542
[TBL] [Abstract][Full Text] [Related]
34. Prevention of colorectal cancer through the use of COX-2 selective inhibitors.
Peek RM
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S50-6. PubMed ID: 15309515
[TBL] [Abstract][Full Text] [Related]
35. Cyclooxygenase-2 inhibition prevents migration of colorectal cancer cells to extracellular matrix by down-regulation of matrix metalloproteinase-2 expression.
Leung E; McArthur D; Morris A; Williams N
Dis Colon Rectum; 2008 Mar; 51(3):342-7. PubMed ID: 18228100
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis.
Cornetta AJ; Russell JP; Cunnane M; Keane WM; Rothstein JL
Laryngoscope; 2002 Feb; 112(2):238-42. PubMed ID: 11889377
[TBL] [Abstract][Full Text] [Related]
37. Low-Dose Aspirin Acetylates Cyclooxygenase-1 in Human Colorectal Mucosa: Implications for the Chemoprevention of Colorectal Cancer.
Patrignani P; Sacco A; Sostres C; Bruno A; Dovizio M; Piazuelo E; Di Francesco L; Contursi A; Zucchelli M; Schiavone S; Tacconelli S; Patrono C; Lanas A
Clin Pharmacol Ther; 2017 Jul; 102(1):52-61. PubMed ID: 28139830
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 expression and prostanoid biogenesis reflect clinical phenotype in human colorectal fibroblast strains.
Zhu Y; Hua P; Lance P
Cancer Res; 2003 Jan; 63(2):522-6. PubMed ID: 12543811
[TBL] [Abstract][Full Text] [Related]
39. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
Reddy BS
Environ Mol Mutagen; 2004; 44(1):26-35. PubMed ID: 15199544
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin-independent effects of aspirin on cell cycle and putrescine synthesis in human colon carcinoma cells.
Eklou-Kalonji E; Andriamihaja M; Reinaud P; Mayeur C; Camous S; Robert V; Charpigny G; Blachier F
Can J Physiol Pharmacol; 2003 May; 81(5):443-50. PubMed ID: 12774850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]